fda approved indications for tirzepatide approves new weight-loss drug Zepbound (tirzepatide) FDA Approves Mounjaro (tirzepatide) Injection

Combining GLP-1 Medications with Weightlifting and Nutrition Building a Synergistic Approach By integrating exercise, supplementation, and diet, patients maximize the benefits of GLP-1 medications

Look for liposomal formats that ensure the nutrients reach your cells

& Anders, M

These are considered anorectic drugs

Results from the FLOW trial, which assessed semaglutide (Ozempic, Novo Nordisk) in adults with type 2 diabetes and CKD, were first presented at the European Renal Association Congress and published in The New England Journal of Medicine in May

One key study cited that 1.5% of users taking 0.5 mg doses of Ozempic developed gallstones, while another study showed a risk of up to 1.27 times higher for gallbladder conditions when using glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the class of drugs to which Ozempic belongs